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A B S T R A C T
Cerebral dopamine neurotrophic factor (CDNF) is neuroprotective for nigrostriatal dopamine neurons and re-
stores dopaminergic function in animal models of Parkinson's disease (PD). To understand the role of CDNF in
mammals, we generated CDNF knockout mice (Cdnf−/−), which are viable, fertile, and have a normal life-span.
Surprisingly, an age-dependent loss of enteric neurons occurs selectively in the submucosal but not in the
myenteric plexus. This neuronal loss is a consequence not of increased apoptosis but of neurodegeneration and
autophagy. Quantitatively, the neurodegeneration and autophagy found in the submucosal plexus in duodenum,
ileum and colon of the Cdnf−/− mouse are much greater than in those of Cdnf+/+ mice. The selective vul-
nerability of submucosal neurons to the absence of CDNF is reminiscent of the tendency of pathological ab-
normalities to occur in the submucosal plexus in biopsies of patients with PD. In contrast, the number of sub-
stantia nigra dopamine neurons and dopamine and its metabolite concentrations in the striatum are unaltered in
Cdnf−/− mice; however, there is an age-dependent deficit in the function of the dopamine system in Cdnf−/−
male mice analyzed. This is observed as D-amphetamine-induced hyperactivity, aberrant dopamine transporter
function, and as increased D-amphetamine-induced dopamine release demonstrating that dopaminergic axon
terminal function in the striatum of the Cdnf−/− mouse brain is altered. The deficiencies of Cdnf−/− mice,
therefore, are reminiscent of those seen in early stages of Parkinson's disease.
1. Introduction
Parkinson's disease (PD) is a neurodegenerative disorder char-
acterized by progressive degeneration of dopamine neurons in the
substantia nigra pars compacta (SNpc), dramatic decreases in brain
dopamine (DA) concentrations, and deficits in motor behavior. PD pa-
tients also suffer from dysfunctional gastrointestinal (GI) motility,
especially constipation, which frequently occurs before the movement
disorder (Pfeiffer, 2003). The exact reason for the GI motility dys-
function in PD is not known; however, deficiencies of enteric dopami-
nergic and non-dopaminergic neurons have been reported in PD
patients (Braak et al., 2006; Chalazonitis and Rao, 2018; Kupsky et al.,
1987; Lebouvier et al., 2010; Rao and Gershon, 2016; Singaram et al.,
1995).
We and others have shown that CDNF protects midbrain dopamine
neurons and restores dopaminergic function in neurotoxin-induced
animal models of PD (Airavaara et al., 2012; Garea-Rodriguez et al.,
2016; Lindholm et al., 2007; Ren et al., 2013; Voutilainen et al., 2011).
Although genome-wide association studies for PD have not identified
mutations in the CDNF gene, a study of early-onset PD patients iden-
tified a single nucleotide polymorphism in the intron between exon 1
and 2 of CDNF (Choi et al., 2011).
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CDNF and a related protein, mesencephalic astrocyte-derived neu-
rotrophic factor (MANF) (Apostolou et al., 2008; Lindholm et al., 2008;
Lindholm et al., 2007; Mizobuchi et al., 2007; Petrova et al., 2003;
Voutilainen et al., 2009), form a novel family of cytoprotective factors
with two distinct domains, an N-terminal, possibly lipid and membrane
interacting domain, and a C-terminal domain containing a non-cano-
nical ER-retention sequence and a conserved CXXC sequence. In fact,
MANF, but not CDNF, has been found to bind to lipid sulfatides present
on the outer leaflets of plasma membranes, which promotes cellular
uptake of MANF and cytoprotection from hypoxia-induced cell death
(Bai et al., 2018). CDNF transcripts and protein are expressed, not only
in SNpc neurons, but also in several additional areas of the adult mouse
and human brain, as well as in multiple peripheral tissues (Lindholm
et al., 2007). CDNF and MANF proteins are located mainly in the ER
lumen and MANF is secreted upon ER calcium depletion (Apostolou
et al., 2008; Glembotski et al., 2012; Henderson et al., 2013; Lindholm
et al., 2008; Lindholm et al., 2007; Matlik et al., 2015; Petrova et al.,
2003).
Endoplasmic reticulum stress is caused by the accumulation and
aggregation of misfolded proteins in the ER, which activates the un-
folded protein response (UPR), an adaptive pathway that tends to re-
store protein and ER homeostasis (Wang and Kaufman, 2016).
Chronically activated UPR has been associated with neuronal dys-
function and cell death in neurodegenerative diseases such as PD and
Alzheimer's disease (Hoozemans and Scheper, 2012; Lindholm et al.,
2006). MANF regulates ER stress; moreover, ER stress regulates MANF
expression and secretion in vitro and in vivo (Apostolou et al., 2008;
Glembotski et al., 2012; Lindahl et al., 2014; Lindahl et al., 2017; Tseng
et al., 2017). Less is known about the function of CDNF in ER stress than
of MANF. In contrast to MANF, CDNF expression is not upregulated in
tunicamycin-induced ER stress in the osteosarcoma U2OS cell line
(Apostolou et al., 2008). CDNF, however, has been shown in vitro to
alleviate ER stress and synaptotoxicity and thus to protect primary
hippocampal neurons from Aβ oligomer-induced neurotoxicity (Zhou
et al., 2016). This observation may account for the finding that CDNF
overexpression in the brains of APP/PS1 transgenic animals improves
long term memory (Kemppainen et al., 2015). Recombinant CDNF also
downregulates activated UPR pathways in vivo in 6-hydroxydopamine
(6-OHDA)-lesioned rat brain and in vitro after thapsigargin-induced ER
stress in fetal mouse midbrain neurons (Voutilainen et al., 2017). Al-
though CDNF is currently being tested in a phase I-II clinical trial in PD
patients (Huttunen and Saarma, 2019), very little is known about CDNF
effects in vivo and nothing is known about the biological role of en-
dogenous CDNF.
To understand the physiological roles of CDNF in mammals, we
generated Cdnf−/− mice. We found that an age-dependent loss of
neurons occurs selectively in the submucosal plexus of Cdnf−/− mouse
gut along with a slowing of GI motility (Chalazonitis et al., 2013) Age-
dependent abnormalities occurred in D-amphetamine responses in
Cdnf−/− mice, demonstrated by hyperactivity, aberrant function of the
dopamine transporter (DAT), and altered dopamine release at dopa-
minergic axon terminals in the striatum.
2. Materials and methods
2.1. Ethics statement and mice
All experimental procedures involving mice in Finland were ap-
proved by the National Animal Experiment Board. Mice were main-
tained in a pathogen-free facility with a 12 h light/dark cycle and un-
limited access to food (Harlan, Teklad Global, 16% protein rodent diet,
2016) and water. In all studies in which Cdnf+/+ and Cdnf−/− mice
were compared, we used sex-matched siblings derived from crossings of
Cdnf heterozygous (Cdnf+/−) animals either in a hybrid Ola129/
C57BL/6JRcc/ICR mixed genetic background or in a C57BL/6JRcc
background (backcrossed for more than six generations). For behavioral
studies homozygotic mice derived from heterozygotic parents were
used in the breeding. For mice used in GI studies, cohorts of age-mat-
ched Cdnf+/+ and Cdnf−/− mice bred from heterozygous parents were
sent from the University of Helsinki to Columbia University animal
facilities and were housed in an isolated room to readapt after transport
for at least three days. All subsequent procedures were approved by the
Animal Care and Use Committee of Columbia University. Mice were
analyzed at 5 representative ages 1.5 months, 3–4 months, 5–6 months,
9–12 months and 24 months old.
2.2. Construction of Cdnf-targeted mice and animals used
CDNF positive clones of mouse BAC-129 SvEvTac RP-22 library
filters (BACPAC Resources, CHORI) were identified by dot-blotting
using 32P-dCTP radiolabeled full-length mouse CDNF cDNA. Positive
chromosomal BAC DNA clones were purchased from CHORI and am-
plified according to the manufacturer's instructions. To create the
knock-out gene-targeting construct, 5´UTR and 3´UTR chromosomal
regions (approximately 6 kb) flanking CDNF exons 2–4 were PCR am-
plified from 129/Svev genomic BAC clones containing CDNF genomic
locus using primers with suitable restriction sites (5´UTR F PmeI 5´-ACT
AGT TTA AAC GAG GAG ACT TGC TTC TCT GC-3′, R AscI 5′-ATA TGG
CGC GCC TAC AAA TGC ATT ACA TTC AGG-3′ and 3´UTR F Not1 5′-
ATA AGC GGC CGC CGA AGA GTC ACT TGG GCT CAG G-3′, R Not1 5′-
ATA AGC GGC CGC CCC AGC TAT CCT CTC TTT CAG ATG G-3′). PCR
fragments (5´UTR 5593 bp and 3´UTR 5608 bp) were isolated from
crystal violet gels and subcloned into a TOPO® XL Cloning vector
(Invitrogen). Restriction analysis was used to investigate fragments;
thereafter, they were digested from TOPO vectors PmeI/AscI (5´UTR)
and NotI (3´UTR) and cloned into a digested CIAP-treated gene re-
placement vector pFlexible (van der Weiden et al., 2005, Gene bank
acc. Nr CR847878) containing a phosphoglycerate kinase (PGK)-driven
positive/negative selection marker puromycin/tka cassette flanked by
Frt and LoxP recombination sites. The functionality of Flp- and Cre-
recombinase sites in the final targeting construct were tested in E.coli
strains expressing Flp- or Cre-recombinase. Plasmids were isolated and
successfully recombined plasmids were identified by restriction ana-
lysis. The targeting construct was linearized with Cla1, purified with a
QiaexII Gel Extraction kit (Qiagen), and electroporated into IB10 (129/
Ola) embryonic stem cells. ES clones were selected with puromycin for
7 days and about 200 clones were picked under a microscope and ex-
panded. The chromosomal DNA was isolated from all clones and suc-
cessful vector integration by homologous recombination was verified
by real-time quantitative PCR (Loss-of Native–allele assay). Positive
qPCR clones were identified by Southern blotting to ensure single in-
tegration. For Southern blotting, DNA from ES cells was digested with
EcoRV and hybridized to a 300 bp 5´UTR 32P-dCTP radiolabeled CDNF
probe generated by PCR from BAC DNA using primers F 5′-AAA GGC
AGA GGG AGC TAA GG-3′, R 5´-TGC ATG GTG GTT GAG TTT TG-3′.
Positive ES clones generated a targeted band of 9.0 kb and a 13.6 kb
band, which represents the wild-type allele. Two genetically modified
ES-cell clones were karyotyped for correct chromosome number and
aggregated with morula-stage pre-implantation embryos (ICR strain) at
the GM mouse unit, University of Helsinki Laboratory Animal Center.
The resulting chimeric mice were bred to ICR mice. Heterozygous CDNF
mice with germ-line transmission of the targeted allele were obtained
from both ES clones. Mice were genotyped by PCR using the following
primers (see arrowheads in Fig. 1A) f2 5’-GCA GCC CCC TTT ATA GTG
GG-3′, f3 5´-TCT GAG GCG GAA AGA ACC AG-3′ and r2 5′-TTG GAC
ATC ACT TTC TGC CTC TC-3′. To remove the puromycin cassette,
heterozygote CdnfPu/+ (Fig. 1A) mice were crossed to transgenic mice
ubiquitously expressing CaqFlp recombinase (Lindahl et al., 2014).
Mice were genotyped with CaqFlp primers (Fig. 1A) f 5′ and f1 5’-CAG
AAC CCC AAA GAA TGC TTA GG-3′, r1 5’-GGC TCA GCA ATT AAG AGC
ACA TG-3′ and r2 5′-TTG GAC ATC ACT TTC TGC CTC TC-3′.
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2.3. RNA isolation, reverse transcription (RT) and quantitative (Q)PCR
RNA from tissues was isolated with TriReagent® (Molecular
Research Center) or by using NucleoSpin RNA® II (Macherey-Nagel)
according to the manufacturer's instructions. Reverse transcription re-
actions were carried out with RevertAid™ Premium Reverse
Transcriptase (Fermentas UAB, Thermo Fisher Scientific Inc.), and
dNTP mix, 10 mM each (Fermentas UAB), oligo(dT)15 primers, 500 μg/
ml (Promega Corporation) for 40 min at 55 °C according to the man-
ufacturer's protocol. Quantitative PCR was performed using
LightCycler® 480 SYBR Green I Master Mix (Roche Diagnostics GmbH)
and a Roche LightCycler® 480 Real-Time PCR System. The expression
levels were normalized to the levels of β-actin in the same samples.
2.4. Primer sequences used in QPCR and RT-PCR
Primer sequences used to synthesize primers for RT-PCR and QPCR
are listed in Lindahl et al., 2014 and below: Atf6β, Forward (F) 5´-CAG
CCA TCA GCC ACA ACA AG-3′, Reverse (R) 5´-GGC ATC ACC AGC GAC
ATC TT-3′, Cdnf exons 1–2 F 5′- CCG AGG GCT GAC TGT GAA G-3′, R
5´-GCA GAA AAG TCT ATG CCT CTG C-3′, Cdnf full (used in Fig. 1C) F
5´-ACC ATG CGG TGC ATC AGT CCA ACT-3′, R 5′-GAG CTC CGT TTG
(caption on next page)
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GGG GTA TAT C-3′. Manf Exons 3–4 (used in Fig. 6J and Supplemental
Fig. 2B) F 5′- GAC AGC CAG ATC TGT GAA CTA AAA-3′, R 5′- TTT CAC
CCG GAG CTT CTT C-3′.
2.5. Immunocytochemistry and quantitation of neurons
2.5.1. Optical density of TH- and DAT-immunoreactive fibers in the
striatum
To analyze the striatal innervation from substantia nigra dopamine
neurons, TH- and DAT-immunoreactive fibers were analyzed in the
striata of Cdnf−/− and Cdnf+/+ littermates. The striata from 4% for-
maldehyde (prepared from paraformaldehyde [PFA]) fixed and par-
affin-embedded brains were cut into 5-μm sections and 5 to 6 sections
spanning the striatum were selected for immunostaining. For analyzing
MANF expression in the gut, parts of the duodenum, jejenum ileum and
colon of WT adult mice were formaldehyde-fixed, embedded in paraffin
and sectioned at 5 μm. Antigen retrieval was carried out by boiling
sections in 10 mM citrate buffer, pH 6, for 10 min. Endogenous per-
oxidase was inactivated by incubation with 0.6% H2O2 in Tris-buffered
saline (TBS). Sections were blocked with 1.5% goat serum in TBS with
0.1% Tween 20 and incubated overnight with antibodies to TH (dil.
1:1000, Millipore, #MAB318, RRID:AB_2201528), DAT (dil. 1:1000,
Millipore, #MAB369, RRID:AB_2190413) or MANF (dil. 1:300,
Icosagen, #310–100, batch A12ManfPab-005, RRID: AB_1135308).
After incubation with biotinylated secondary antibodies (1:200, Vector,
BA-2000, BA-9400), immunostaining was visualized with 3′,3′-diami-
nobenzidine chromogen amplified by avidin-biotin complex formation
(ABC kit, Vector). To decrease the background, sections were scanned
with an automated scanner (3DHistech, Budapest, Hungary; the scan-
ning service was provided by the Institute of Biotechnology, University
of Helsinki; http://www.biocenter.helsinki.fi/bi/histoscanner/index.
html), and the images were converted to a 16-bit gray scale. The
corpus callosum, which is devoid of TH or DAT, was used to estimate
nonspecific background staining. The integrated densities divided by
area from the obtained images were analyzed with ImageJ (NIH) soft-
ware.
2.5.2. Stereological assessment of TH-reactive neurons in substantia nigra
For immunocytochemistry, mice were perfused transcardially with
phosphate-buffered saline (PBS, pH 7.5), 4% formaldehyde (from PFA)
and tissues were postfixed with 4% formaldehyde (from PFA) for at
least 12 h. Tissues were cryoprotected with 20% sucrose in PBS. To
assess the total number of TH+ neurons in the SNpc, we used 40 μm
free-floating cryosections, which were stained with antibodies to TH
(Millipore, #MAB318), and visualized with 3′,3′-diaminobenzidine.
Three slides from each animal from the same regions of the SNpc, were
selected for quantitation with a Stereo Investigator platform
(MicroBrightField) attached to an Olympus BX1 microscope as de-
scribed previously (Mijatovic et al., 2007; Voutilainen et al., 2009). To
quantify dopaminergic neurons in that SNpc and ventral tegmental area
(VTA), the 5-μm-thin paraffin sections from the SN were im-
munostained with antibodies to TH (dil. 1:1000, Millipore, #MAB318)
and counterstained with hematoxylin. Images were captured with
3DHistech scanner; a region of the SNpc or the VTA was cropped and
TH-immunoreactive neurons were counted with a Matlab algorithm,
which recognizes cells based on their intensity and size (Penttinen
et al., 2016). Intensity threshold was determined separately for each
section, but the threshold for the cell size was kept constant. Neurons in
the SNpc from one hemisphere and the VTA region from both hemi-
speres were counted in 3 to 4 sections per animal and represented as an
average.
2.5.3. Immunohistochemistry and quantitation of neurons of the small
intestine and colon
Methods were similar to those previously described (Chalazonitis
et al., 2008; Chalazonitis et al., 2011; Pham et al., 1991). Briefly, mouse
small intestine or colon were isolated, their lumen was flushed with
Krebs solution, and tissues were fixed with phosphate-buffered 4%
formaldehyde (from PFA) at pH 7.4. Laminar preparations containing
the myenteric (MyP) or submucosal (SMP) plexuses were then dissected
from duodenum, jejunum, ileum, and colon. Neurons were identified
with biotinylated monoclonal antibodies to HuC/D (Thermo Fisher
Scientific, Molecular Probes Cat# A-21272, RRID: AB_2535822);) or a
polyclonal anti-human neuronal nuclear antigen ANNA-1 [gift of Vanda
Lennon, Mayo Clinic, Rochester MN at 1:40000; King et al., (1999)]
that cross-reacts with mouse neurons (Margolis et al., 2016). Sites
where these primary antibodies were bound were visualized, respec-
tively, with streptavidin Alexa 594 (Thermo Fisher Scientific, Molecular
Probes, diluted 1:400) and donkey anti-human secondary antibodies
coupled to Alexa 488 (Thermo Fisher Scientific, Molecular Probes; di-
luted 1:400).
2.5.4. Neuronal quantitation
Neurons in whole mounts of laminar preparations containing the
SMP were examined with an upright fluorescence microscope (Leica
DMRXA2), using a 40× objective. Neurons were counted by an ob-
server who was blinded to the genotype of the tissue. Three in-
dependent determinations were made for each region of gut in each
animal. Neuronal cell bodies were enumerated in contiguous, non-
overlapping rectangular fields, which were scanned across the width
and length of each whole mount. A single measurement was defined as
the sum of neurons in 10 fields covering an area of 1.25 mm2. The
numbers of measurements ranged from 71 to 80 (in juvenile), 60 to 70
(in young adult) and 99–102 (in mature adult) animals. Because the
total number of enteric neurons varies as a function of animal age,
neuronal density was expressed both as neurons per mm2 and as %
wild-type at each age examined. Immunofluorescence images were
obtained with a digital CCD camera (Retiga Exi), mounted on a Leica
Fig. 1. Cdnf knockout mice are viable, fertile and show no obvious gross phenotypes. (A) Schematic illustration of the WT Cdnf+/+ and targeted CdnfPu/Pu and Cdnf−/
− loci. Arrowheads indicate priming sites used in genotyping by PCR and in RT-PCR. A PGK-promoter driven puromycin selection cassette (Puro∆tk), exon (E), Frt
(F)-site, LoxP (L)-site. (B). Example of genotyping result. Genotyping of mice was performed by PCR using primers forward 1 (f1), forward 2 (f2) and forward 3 (f3)
and reverse 2 (r2), indicated by arrowheads in (A). Amplified band of 201 bp represents WT Cdnf+/+, band of 300 bp represents the targeted CdnfPu/Pu allele, where
puromycin cassette is included (left panel). In the right panel, amplified band of 400 bp represents the targeted allele from which the puromycin cassette has been
deleted, and the 271 bp band the WT band. MWM; molecular weight marker. (C) RT-PCR analysis for Cdnf andManfmRNA expression in tissues from adult Cdnf+/+
and Cdnf−/− mice. Primers for Gapdh were used to normalize mRNA levels in each sample. (D) Western blot analysis of tissue-lysates confirms that CDNF protein is
not expressed in tissues of Cdnf−/− mice. Recombinant human CDNF protein (rhCDNF) was used as a positive control and anti-actin antibody for normalization of
total protein content. (E) Growth curve of Cdnf+/+ (n= 5) and Cdnf−/− (n= 5) littermate male mice. Body weight was measured weekly from postnatal day (P) P3
to 11 weeks of age (two-way RM ANOVA, interaction of genotype and time, F(11,88) = 1.08, p= .387). Weight of 1 year-old Cdnf+/+ and Cdnf−/− female and male
mice in (F) C57BL/6 background (n = 6–14, two-tailed t-test), and (G) ICR/C57BL/6 mixed background (n= 6, two-tailed t-test, males; Mann Whitney U test). (H)
Analysis of the indicated components from blood serum of 1 year-old Cdnf+/+ (n= 12) and Cdnf−/− (n= 14) male mice. Differences were analyzed with t-test and
calcium content by t-test with Welch's correction. (I) Ad libitum fed blood glucose levels from 1 year-old Cdnf+/+ and Cdnf−/− mice in C57BL/6 background
(n= 19–20, males; t-test (Welch's correction) and mixed background (n= 9–10, males; t-test). (J) Organ weights normalized to body weight did not differ between
genotypes in 2 year-old (males, n = 4, 5) Cdnf+/+ and Cdnf−/− mice (t-test; for brain, liver, gut, testicles and spleen, Mann Whitney U test). Mean ± SEM. F,
female, M, male.
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DM 6000B microscope. Images were obtained with computer assistance
(Volocity 6.3 software; Improvision/PerkinElmer Life and Analytical
Sciences). Adobe CS5 Photoshop software was used to assemble mon-
tages.
2.5.5. Glial quantitation
Cross-sections from ileum and colon of juvenile Cdnf+/+(15–20
measurements) and Cdnf−/− (16–24 measurements) animals, cut in a
cryostat-microtome, were processed to demonstrate the im-
munoreactivity of the glia marker, S100β (rabbit polyclonal antibodies
dil 1:500; DAKO, # Z0311; RRID:AB_10013383) and the nuclear DNA
marker, bisbenzimide (dil 1:1000; Hoechst 33258, Thermo Fisher
Scientific, #H3569; RRID:AB_2651133). The density of glia in the en-
teric plexuses was quantified as the ratio of the fluorescence intensity of
S100β-immunoreactivity (green fluorescence) to that of DNA (blue
fluorescence). Computer-assistance was used to quantify fluorescence
intensity (Volocity 6.3 software). Regions of interest (ROIs) were deli-
neated within the sections such that myenteric and submucosal
plexuses, as well as the deep muscle plexus and the nerves within the
muscularis externa were included.
2.5.6. Neuronal apoptosis
Segments of ileum and colon from 1.5 month-old animals were
prepared to obtain optically cleared whole mounts of the entire bowel
wall (Rao et al., 2015; Wilson et al., 2011). Tissues (1.5 cm in length)
were cleaned, the mesentery was removed, the bowel was opened
longitudinally, pinned flat, and fixed for 2 h at 4 °C. Neurons were
identified with ANNA-1 antibodies (diluted 1:40,000) and apoptotic
cells were detected with an early marker of apoptosis, the phosphory-
lated histone H2A.X (PH2A.X) using rabbit monoclonal antibodies (Cell
Signaling Technology, Cat# 9718, RRID: AB_2118009) diluted 1:200,
for 48–72 h (Holubec et al., 2005; Lu et al., 2006; Rogakou et al., 2000;
Wilson et al., 2011). Sites of primary antibody binding were detected
with species-specific goat secondary antibodies coupled, respectively to
Alexa 488 or Alexa 594 (Invitrogen; diluted 1:500). Preparations were
washed, dehydrated with graded methanol, and optically cleared with
benzyl alcohol–benzyl benzoate (BABB). Neurons in the optical planes
of the submucosal and myenteric plexuses were quantified as described
above except that a 20 × objective was employed and neurons were
counted in a 3-dimensional volume of 0.09 mm3 of tissue; the numbers
of such individual measurements ranged from 65 to 91.
2.5.7. Degenerating neurons
To identify enteric neurons which were in the process of degen-
erating rather than undergoing apoptosis, histochemical staining using
Fluoro-Jade C (FJC) was applied as a specific marker (Bian et al., 2007;
Ehara and Ueda, 2009; Hoang et al., 2009; Schmued et al., 1997).
Sections of frozen blocks of ileum and duodenum isolated from gut of
juveniles Cdnf−/− and Cdnf+/+ littermates were first treated for
fluorescence immunocytochemistry with human ANNA-1 antibodies
(1:10,000) followed with DyLight 594 Goat anti-human IgG (1:300) to
label all neurons. Sections were then post-fixed, exposed to KMnO4,
then transferred to a solution of FJC (0.0001% in acetic acid) and in-
cubated for 10 min. The sections were then rinsed in deionized H2O and
mounted in an acidic mounting medium. Subsets of FJC-labeled neu-
rons were identified with green fluorescence and analyzed in both
myenteric and submucosal plexuses. Quantitation of FJC-labeled neu-
rons was expressed as % of total ANNA-1 labeled neurons in each
plexus. Proportions of FJC-labeled neurons per section were obtained
from 8 (duodenum), 12 (ileum), 20 (colon) sections of Cdnf+/+ and
from 11 (duodenum), 15 (ileum), 27 (colon) sections of Cdnf−/− lit-
termates. Data were expressed as the means± standard error.
2.5.8. Density of autophagosomes
To quantify the density of autophagosomes, whole mounts con-
taining the SMP were prepared from mature adult (9–12 months) mice.
Rabbit antibodies to microtubule-associated protein 1A/1B-light chain
3 (LC3; Novus Biologicals, Cat# NB100-2331SS, RRID: AB_791016)
diluted 1:100–1:75) were used to identify autophagosomes (Hung et al.,
2014). ANNA-1 was employed as a neuronal marker. Sites of bound
primary antibodies were identified, respectively, with Alexa 488-la-
beled goat anti-rabbit and donkey Alexa 594-labeled anti-human sec-
ondary antibodies. A 100× objective was used to identify and quantify
LC3-immunoreactive puncta in the cell bodies of identified neurons. For
quantitation, the sum of these puncta was determined within a field of
cytoplasm narrowed to 7.85 μm2. This sum per cell soma was defined as
one count and a single measurement was defined as the mean of 10
counts. Twelve such measurements were made from each type of mouse
and means were statistically compared. Background counts of puncta
were ascertained in similar preparations that were treated identically,
except that primary antibodies to LC3 were omitted. Again, counts were
obtained while blinded to the genotype of the tissue. To validate and
confirm immunocytochemical observations, neurons were also ex-
amined electron microscopically. For this purpose, gut was fixed by
immersion in a freshly prepared mixture of 4% formaldehyde and 0.2%
glutaraldehyde in 0.1 M phosphate buffer, pH 7.4. Tissues were post-
fixed with 2% OsO4 for 1 h, stained en bloc with 5% aqueous uranyl
acetate, dehydrated in a graded series of ethanols, cleared with pro-
pylene oxide, and embedded in Epon 812 (Ted Pella, Redding, CA).
Sections (80 nm) were collected on copper grids and examined with a
JEOL 1200EX electron microscope. The density of morphologically
identified autophagosomes in each electron micrograph was normal-
ized to 10−3 μm2 of ganglionic area. These data were also expressed as
the % determined in Cdnf+/+ mice. Measurements were made in 25–55
individual neurons in each plexus of ileum and colon in Cdnf+/+ and
Cdnf−/− mice.
2.6. Western blot analysis
Tissues were homogenized in lysis buffer (100 mM Tris-HCl, pH 7.5,
300 mM NaCl, 4 mM EDTA, 2% BSA, 0.2% Triton X-100, 2 mM PMSF,
1 mM sodium orthovanadate, protease cocktail inhibitor (Complete,
Mini EDTA, Boehringer Mannheim), incubated on ice for 15–30 min,
and centrifuged at 13000 rpm for 30 min. For detection of CDNF pro-
tein, 1 M HCl was added to the supernatant (pH < 2), and the samples
were incubated for 30 min on ice. The pH of the samples was adjusted
to pH 7.6 using 1 M NaOH. Protein content was determined by Bradford
protein assay (Bio-Rad). Aliquots of supernatant were mixed in
Laemmli buffer. Proteins were separated by SDS-PAGE and transferred
to nitrocellulose membranes. Immunoblot analysis using antibodies
against CDNF (1:1000, used as determined in (Lindholm et al., 2007)
and actin (1:1000, Sigma, Cat# A3853, RRID: AB_262137, Clone AC40)
were used to identify the protein of interest. Blots were developed using
chemiluminescence ECL Blotting Substrate (Pierce, Thermo Scientific).
DA and its metabolites levels were determined in brain samples by
using HPLC as previously described (Airavaara et al., 2006; Kumar
et al., 2016).
2.7. Analysis of blood samples
Blood glucose levels in randomly fed animals were analyzed using a
glucometer (Accucheck Aviva Glucometer, Roche Diagnostics). For
measurement of constituents of blood, sera were collected by cen-
trifugation of blood collected from heart of freshly euthanized animals
and frozen at −80 °C until used. Clinical chemistry analyses from
serum samples were performed with an automatic analyzer (Konelab
v.7.1.1) according to the manufacturer's instructions in the Central
Laboratory of the Faculty of Animal Medicine, Department of Equine
and Small Animal Medicine, University of Helsinki.
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2.8. Behavioral testing
Novelty-induced locomotor activity in open field (OF): Mice were re-
leased in the corner of a novel open field arena (30 × 30 cm, Med
Associates). Horizontal and vertical activity was recorded for one hour
(light intensity ~150 lx). The peripheral zone was defined as a 6 cm
wide corridor along the wall of the arena.
Forced swim test (FST).Mice were placed for 6 min in a glass cylinder
(diameter 18 cm, height 25 cm) filled with water (23 ± 1 °C) to a
height of 15 cm. The time of immobility was defined as passive floating
with the animal motionless or only slightly moving its tail or a hind
limb. The time of activity was defined as struggling, climbing, or
swimming using all four paws. Times of immobility and activity were
measured at 2 min intervals.
Amphetamine-induced locomotor activity: Mice were habituated in an
open field arena for 30 min. D-amphetamine (3 mg/kg) was then ad-
ministered intraperitoneally and the mice were returned immediately
to the open field for recording of activity during the subsequent 90 min.
GBR 12909-induced locomotor activity: 11 month-old male Cdnf−/−
mice with wild-type controls in an ICR background were habituated in
an open field arena for 30 min. Mice were injected with a selective
dopamine reuptake inhibitor, GBR 12909 (20 mg/kg), placed back into
the arena and activity was monitored for the following 120 min.
2.9. Fast-scan cyclic-voltammetry
Striatal slices (300 μm thickness) were cut on a vibrating microtome
in ice-cold cutting saline containing: 125 mM NaCl, 2.5 mM KCl, 26 mM
NaHCO3, 0.3 mM KH2PO4, 3.3 mM MgSO4, 0.8 mM NaH2PO4, 10 mM
glucose. Slices were allowed to recover for 1–2 h at 35 °C in oxygen-
bubbled (95% O2, 5% CO2) recording saline containing: 125 mM NaCl,
2.5 mM KCl, 26 mM NaHCO3, 0.3 mM KH2PO4, 2.4 mM CaCl2, 1.3 mM
MgSO4, 0.8 mM NaH2PO4, 10 mM glucose. Slices were then transferred
into a recording chamber that was perfused with 35 °C oxygen-bubbled
recording saline. When D-amphetamine was studied, the drug was
added to the perfusing solution (5 μM) after a stable baseline of sti-
mulated transients had been reached. Recordings were carried out with
cylindrical 5 μm carbon fiber electrodes and DA release was stimulated
electrically using a bipolar stainless-steel electrode. Triangular voltage
ramps from a holding potential of −450 mV to +900 mV over 9 ms
(scan rate of 300 mV/ms) were applied to a carbon fiber electrode at
100 ms intervals. Current was recorded with an Axopatch 200B am-
plifier (Molecular Devices) filtered with 5 kHz low-pass Bessel filter and
digitized at 40 kHz (ITC-18 board). Triangular wave generation and
data acquisition were controlled and the recorded transients were
characterized by a computer routine in IGOR Pro (WaveMetrics)
written by Eugene Mosharov (http://sulzerlab.org/download.html).
Background-subtracted cyclic voltammograms obtained with a known
concentration (1 μM) of DA solution were used to calibrate the elec-
trodes and to identify DA.
2.10. Experimental design and statistical analyses
The overarching design of the studies was to analyze the effects of
CDNF on the midbrain and the ENS in juvenile, young adult, mature
and aged animals. For studies of the brain, significance of differences
between two groups was analyzed by Student's unpaired two-tailed t-
test using Microsoft Excel software. Differences between more than two
groups were calculated by one-way analyses of variance (ANOVA)
followed by appropriate post-hoc analysis, using the SPSS Inc. PASW
Statistics 18 program. For statistical analysis of quantified numbers of
dopaminergic neurons, Stereoinvestigator software was employed and a
t-test with Welch's correction was used to compare groups. Results are
expressed as means± standard error of the mean and were considered
significant if p < .05. For quantitation of neuronal densities in enteric
plexuses, and autophagosome density results, GraphPad Prism software
(version 7.0) was used to calculate means and standard errors as well
for tests of statistical significance. Means were compared with Students
unpaired t-test and multiple means were compared with one-way
ANOVA. Tukey or Bonferroni-Dunn methods were employed for post-
hoc comparisons. For behavioral studies, factorial ANOVA with geno-
type and strain as independent variables were used. Locomotor activity
in an open field was analyzed by repeated measures ANOVA for 5-min
intervals with genotype and treatment as independent variables.
Voltammetry data was analyzed by GraphPad Prism software (version
6.0), using two-way ANOVA (age and genotype) and Tukey's multiple
comparisons. Statistical details of individual experiments are presented
with the relevant results in the figure legends.
3. Results
3.1. Cdnf−/− mice are viable, fertile, and do not show an obvious growth
defect
We generated conventional Cdnf−/− mice by replacing exons 2–4 in
the endogenous Cdnf locus with a targeting construct containing a PGK-
driven positive/negative selection marker cassette in between the
5´UTR and 3´UTR chromosomal homology arms (Fig. 1A). The resulting
heterozygous CdnfPu/+ mice were viable and fertile; however, growth
of homozygous CdnfPu/Pu embryos was delayed and premature em-
bryonic lethality occurred before embryonic day (E) 12, probably due
to a defect in chorioallantoic fusion, which caused a hydropic allantois
and a failure in umbilical cord formation (not shown). The puromycin
cassette was therefore removed from the locus by crossing heterozygote
Cdnf+/− mice with ubiquitous Flp-recombinase expressing mice
(Fig. 1A). The resulting homozygous Cdnf−/− mice were viable and
fertile, suggesting that the puromycin cassette in the homozygous
CdnfPu/Pu mice interfered with vital genes (not shown). We continued
our analysis with the viable Cdnf−/− mice, lacking the puromycin
cassette and exons 2–4. Absence of transcripts encoding CDNF and
protein from tissues of Cdnf−/− mice was verified by semi-quantitative
RT-PCR (Fig. 1C) and Western blotting (Fig. 1D). There was no sig-
nificant difference in weight-gain between mice of different genotypes
measured weekly from post-natal day 3 (P3) until 3 months of age
(Fig. 1E). No difference in weight between genotypes was found in 1
year-old mice of either inbred C57BL/6JRcc or ICR/mixed genetic
background (Fig. 1F-G). Clinical biochemistry parameters in sera from
Cdnf−/− mice did not differ from WT mice (Fig. 1H). Because Manf−/−
mice suffer from diabetes mellitus (Lindahl et al., 2014), we measured
blood glucose levels from ad libitum fed 1 year-old animals. Cdnf−/−
mice in both mixed and C57BL/6 background had normal blood glucose
levels (Fig. 1I). Finally, organ weights in Cdnf−/− mice were not sig-
nificantly different from those of Cdnf+/+ mice measured in 2 year-old
animals. We can therefore conclude that CDNF ablation in mice does
not cause gross phenotypic defects.
3.2. Age-dependent hypoplasia and non-apoptotic neuronal degeneration
occurs in the submucosal plexus but not in the myenteric plexus of mice
lacking CDNF
Transcripts encoding Cdnf are expressed in the murine gut of adult
wild-type mice (Lindholm et al., 2007). We found, that transcripts en-
coding CDNF were present in the stomach, intestine and colon of mice
as early as postnatal day 7 (P7) (Fig. 2A). We have previously reported
that CDNF transcripts are expressed in enteric neural crest-derived cells
as early as E16 (Chalazonitis et al., 2013). These observations suggest
that CDNF is expressed during a period when ENS neurogenesis, which
declines after P21, is active (Pham et al., 1991; Chalazonitis et al.,
2013). Because CDNF is expressed in the bowel, we determined the
effect of its deletion on the numbers of neurons in the ENS at different
ages. The densities of neurons (neuronal numbers/unit area) in the
distal small intestines of Cdnf+/+ and Cdnf−/− mice were compared in
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1.5 month-, 3 month-, and 9–12 month-old mice (Fig. 2B-D). These data
were also expressed as % of change in neuronal number (Fig. 2B). In
both Cdnf+/+ and Cdnf−/− mice, neuronal density was greater in
3 month-old than in 1.5 month-old mice, reflecting the post-natal ma-
turation of the ENS (Fig. 2B-D; compare D1 with D2 and D4 with D5).
Neuronal density declined in 9–12 month-old mice, reflecting the
known (Liu et al., 2009) age-dependent loss of enteric neurons (Fig. 2B
and D; compare D3 with D6). Neuronal density, in Cdnf−/− mice,
however, was significantly lower than that of Cdnf+/+ animals at every
age examined. This hypoplasia of the submucosal plexus (SMP) of
Cdnf−/− mice was apparent in 1.5 month-old juvenile mice and per-
sisted to adulthood (Fig. 2B). Similar data were obtained in the jejunum
(not shown). The difference between Cdnf+/+ and Cdnf−/− mice was
greater in 1.5 month- and 3 month-old mice, than in 9–12 month-old;
therefore, the age-related loss of neurons was more accentuated in
Cdnf+/+ than in Cdnf−/− animals, (Fig. 2B; compare D2 with D3; D5
with D6). These data are consistent with the idea that the CDNF gene
deletion must affect ENS development and that CDNF has a strong
protective effect on the submucosal neurons in post-natal life and
continues to maintain them with age; alternatively, CDNF may promote
the development of neurons that are especially susceptible to loss as a
function of age.
Because the deletion of CDNF appeared to exert a greater effect on
numbers of neurons in 1.5 month-old than 9–12 month-old mice, we
tested the hypothesis that the deletion leads to apoptosis of enteric
neurons in 1.5 month-old animals. To do so, we quantified both the
numbers of neurons and the proportion that are apoptotic in both en-
teric plexuses of mice at 1.5 months of age. Both small and large in-
testine were examined. In these experiments, the gut wall was not
dissected into laminae but was optically clarified and examined as an
intact whole mount. The packing density of submucosal neurons (de-
monstrated with antibodies to ANNA-1) was again found to be sig-
nificantly lower in Cdnf−/− mice than in Cdnf+/+ mice (Fig. 3A, B).
Neurons undergoing apoptosis were identified using antibodies to
PH2A.X, a marker of double-DNA strand brakes and early apoptosis as
well as DNA repair and replication (Holubec et al., 2005; House and
Koch, 2014; Lu et al., 2006; Rogakou et al., 2000). Although rare
apoptotic neurons were encountered in a minority of both Cdnf+/+ and
Cdnf−/− mice (Fig. 3B insets), the proportion of neurons undergoing
apoptosis was not significantly different from zero in any of the animals
examined (Table 1).
The packing densities of myenteric neurons in Cdnf−/− mice did not
differ significantly from those of Cdnf+/+ animals and again (Fig. 3C,
D), the number of apoptotic neurons was similar in all animal genotypes
(Table 1). These data suggest that although a deficiency in neuronal
density is detectable in Cdnf−/− mice as early as 1.5 months of age,
there is no alteration of the proportion of neurons undergoing apoptosis
in the Cdnf−/− animals. Few apoptotic neurons were detected in either
the ileum or colon of both Cdnf+/+ and Cdnf−/− mice (Table 1).
Since no increased apoptosis could be demonstrated in neurons of
the submucosal plexus in Cdnf−/− mice, slow degeneration could be an
alternative mechanism to explain their declining numbers. To test this
possibility, histochemical analysis using a specific neuronal degenera-
tion marker, Fluoro-Jade C (FJC), was carried out on sections of duo-
denum, ileum, and colon (proximal and distal) from 1.5 month-old
Cdnf+/+ and Cdnf−/− mice. FJC-labeled neurons were quantified as
proportions of total neurons (labeled with ANNA-1) per section in both
submucosal and myenteric plexuses. In the submucosal plexus, the
proportions of FJC-labeled neurons were significantly higher in Cdnf−/
− than in Cdnf+/+ mice in duodenum (Fig. 4A; C–H) ileum (Fig. 4B;
I–K) as well as in colon (Fig. 4C). In contrast, the proportions of de-
generating myenteric neurons in the duodenum (Fig. 4A) and ileum
(Fig. 4B), were significantly lower than in the submucosal plexus;
however, the proportions of myenteric degenerating neurons in Cdnf−/
− mice were not different from those in Cdnf+/+ animals in all three
regions of the gut (Fig. 4A, B, C). These data suggest that neuronal
degeneration, rather than apoptosis probably contributes to the selec-
tive hypoplasia of the submucosal plexus that occurs in Cdnf−/− mice.
Fig. 2. The degree of selective neuronal hypoplasia is sustained as a function of age in the submucosal plexus of Cdnf−/− mice while in the myenteric
plexus the age-dependent decline is similar with no hypoplasia compared to Cdnf+/+ mice; (A) Transcripts encoding CDNF are expressed in stomach, intestine
and colon of the murine gut at P7 but are absent in Cdnf−/− mice. (B) Neuronal densities per mm2 of plexus in the ileal submucosal plexuses, and (C) in the myenteric
plexus in Cdnf−/− mice (magenta solid line) and Cdnf+/+ mice (blue solid line) are plotted as a function of age. The neuronal densities in the submucosal plexus are
significantly lower in Cdnf−/− mice than in Cdnf+/+ mice at each age examined; [B] 2 way ANOVA F(2, 437) = 22.94. There is however some compensation
between 1.5 and 11 month of age in Cdnf−/− mice which does not occur in the Cdnf+/+ mice; [C] in contrast in the myenteric plexus the decline as a function of age
is similar in Cdnf−/− and in Cdnf+/+ mice without compensation between the genotypes. The numbers of animals were 3 Cdnf−/− and 3 Cdnf+/+ for 1.5 month-old
mice; 6 Cdnf−/− and 6 Cdnf+/+ for 3 month-old animals; 7 Cdnf−/− and 7 Cdnf+/+ for 9–12 month-old mice; (D) Immunocytochemical detection of neurons using
antibodies to HuC/D in whole mount laminar preparations of the ileal submucosal plexus in Cdnf+/+ (D1-D3) and Cdnf−/− mice (D4-D6) (scale bar, 32 μm). (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 3. The selective neuronal hypoplasia in the submucosal plexus of Cdnf−/− mice is not the result of increased apoptosis (A) Neuronal densities in the
submucosal plexus of 1.5 month-old mice are significantly less both in ileum and colon of Cdnf−/− mice (n= 6) (magenta,75–91 measurements) than in their Cdnf+/
+ littermates (n = 4) (turquoise, 65–82 measurements). Top graph (neurons/mm2), t-test (with Welch's correction), ileum t = 5.652, df = 112.5; colon t = 8.431,
df = 156. Bottom graph, neurons (%WT); ileum t = 5.652, df = 112.5; colon t=7.567, df = 82.93. (B) Immunocytochemical detection of neurons using antibodies
to ANNA-1 (green) in optically cleared whole mounts of the ileal and colonic submucosal plexuses in Cdnf+/+ and Cdnf−/− mice (scale bar, 70 μm). Two examples of
the very rare apoptotic neurons found in the submucosal plexus in the ileum and colon of Cdnf−/− mice, which are co-labeled with ANNA-1 antibodies (green) and
the nuclear PH2A.X antibodies (magenta) are shown in the insets of the lower panels. A non-neuronal apoptotic cell is shown (inset left upper panel) in the ileum of a
Cdnf+/+ mouse. In the colon, PH2A.X-immunoreactive cells are abundant in the epithelium of the mucosa and in lymphoid follicles (inset right upper panel). (C)
Densities of myenteric neurons differ significantly neither in the ileum nor the colon of juvenile Cdnf−/− mice from those of their Cdnf+/+ littermates. Top graph
(neurons/mm2), t-test (Welch's correction), ileum t = 0.4938, df = 137.2; colon t = 1.449, df = 171. Bottom graph (neuron density %WT), t-test (Welch's
correction), ileum t= 0.4861 df = 138; colon t = 1.449, df = 171. (D) Immunocytochemical detection of neurons using antibodies to ANNA-1 (green) in optically
cleared whole mounts of the ileal and colonic myenteric plexuses in Cdnf+/+ and Cdnf−/− mice (scale bar, 70 μm). (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
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3.3. Autophagy in enteric neurons is greater in Cdnf−/− than in Cdnf+/+
mice
The smaller number of submucosal neurons in Cdnf−/− than in
Cdnf+/+ mice could be due to diminished neuronal differentiation or
survival. An effect on either would be likely to occur if neurons or their
precursors in Cdnf−/− mice were to be more highly stressed than in
Cdnf+/+ animals. Autophagy is a common response of cells to stress
and dysregulation of autophagic mechanisms has been associated with
PD (Lynch-Day et al., 2012; Michel et al., 2016). We thus reasoned that
the occurrence of autophagy would increase in the enteric neurons of
Cdnf−/− mice if they were more susceptible to stress than those of
Cdnf+/+ animals. Antibodies to LC3, which is a marker for autopha-
gosome formation, and the neuronal marker, ANNA-1, were applied
simultaneously to laminar preparations of ileum containing the sub-
mucosal plexus to quantify autophagy in cells identified as neurons.
Studies were carried out with Cdnf+/+ (Fig. 5A-C) and Cdnf−/−
(Fig. 5D-F) 9–12 month-old mice. The density of LC3-immunoreactive
puncta/neuron was significantly greater in Cdnf−/− than in Cdnf+/+
animals (Fig. 5G). These observations are thus consistent with the idea
that the amount of autophagy in submucosal neurons of Cdnf−/− mice
exceeds the constitutive amount seen in submucosal neurons of Cdnf+/
+ animals. EM was employed to extend observations made at the light
microscopic level with LC3 immunoreactivity (Fig. 5J-M). EM has been
shown to be more sensitive and to have a better resolution than im-
munocytochemistry for the detection of autophagic figures in cells
(Eskelinen et al., 2011). Both ileum and colon were examined and au-
tophagic figures were identified and quantified in submucosal and
myenteric neurons of ileum and colon. Early autophagosomes have a
double limiting membrane; however, the double membrane is lost when
the structures fuse with endosomes or lysosomes. Late autophagic fig-
ures can be identified by their content of cytoplasmic material or or-
ganelles. Although the density of autophagosomes in the myenteric
plexus of the Cdnf−/− ileum was not significantly different from that of
Cdnf+/+ animals, the density of autophagosomes in the submucosal
plexus of Cdnf−/− mice was significantly greater than that of their
Cdnf+/+ counterparts (Fig. 5H, J, K). In contrast, the density of au-
tophagosomes was significantly greater in both plexuses of the Cdnf−/−
than of the Cdnf+/+ colon (Fig. 5I, L, M). These results are compatible
with the previously shown neuroprotective properties of CDNF and
suggest that its protective effects are more evident in the submucosal
plexus and in the colon, where neurons may be more stressed than in
the myenteric plexus of the small intestine.
3.4. Density of glia is not different in the enteric plexuses of Cdnf−/− mice
and Cdnf+/+ mice
Sections from 1.5 month-old animals were analyzed to evaluate the
density of glia. Glial density was taken as the ratio of S100 β fluores-
cence to that of DNA demonstrated with bisbenzimide. Measurements
included glia in the submucosal and myenteric plexuses as well as those
in the muscle layers and the deep muscle plexus. Glial density was not
found to be significantly different in either the ileum or colon of Cdnf−/
− and Cdnf+/+ animals (Supplemental Fig. 1).
3.5. The general architecture of midbrain dopaminergic neurons of Cdnf−/
− mice is similar to that of Cdnf+/+ mice at different ages
Because GI abnormalities occur in mature adult Cdnf−/− mice
(Chalazonitis et al., 2013) similarly to those seen in PD patients before
the onset of movement disorders, we analyzed nigrostriatal dopami-
nergic neurons. TH and DAT immunoreactivity were used to analyze
neurite densities and number of nigrostriatal dopaminergic neurons. In
contrast to the neurodegeneration of enteric submucosal neurons that
already occurs in 1.5 month old mice, the number of neurons in the
SNpc and the optical density of TH+ and DAT+ striatal neurites at the
age of 3 months were similar in Cdnf−/− and Cdnf+/+ mice (Fig. 6A-
D). Neuronal numbers (Fig. 6E) and striatal neurites (Fig. 6F) did not
differ between genotypes even in 1 and 2 year-old mice. There were no
differences in the concentrations of DA, 4-dihydroxyphenylacetic acid
(DOPAC) or homovanillic acid (HVA), 5-hydoxytryptamine (5-HT) or 5-
hydroxyindoleacetic acid (5-HIAA) measured with HPLC in the striatal
tissue of one-year old Cdnf−/− and Cdnf+/+ mice (Fig. 6G).
Because MANF deficiency in pancreatic beta cells leads to chroni-
cally elevated UPR (Lindahl et al., 2014) and exogenously added CDNF
can modulate ER stress in animal models of PD (Voutilainen et al.,
2017), we used qPCR to measure the ER stress levels of the SN and
striatum of 9–12 month-old Cdnf+/+ and Cdnf−/− mice. No difference
was detected in the levels of transcripts encoding typical UPR genes in
the SN (Fig. 6H) and striatum (Fig. 6I) of Cdnf−/− and Cdnf+/+ mice.
To investigate whether upregulation of MANF compensates for the loss
of CDNF in the brains of Cdnf−/− mice, we measured transcripts en-
coding Manf. Levels of transcripts encoding Manf were not significantly
different in the SN or striata of Cdnf−/− mice from those in Cdnf+/+
mice (Fig. 6J). MANF is highly expressed at the base of epithelial crypts,
particularly in small intestinal regions (Danilova et al., 2019; Supple-
mental Fig. 2A). This region of the crypt contains Paneth cells and Lgr5-
expressing stem cells. Lower levels of MANF expression were found in
ganglia of the submucosal and myenteric plexuses in the gut than in the
epithelium (Supplemental Fig. 2A). The Manf mRNA levels in the
duodenum of 1.5 year-old Cdnf−/− mice were similar to those of
Manf+/+ mice (Supplemental Fig. 2B), indicating no compensatory
upregulation of MANF expression occurs in the gut of Cdnf−/− mice. In
conclusion, we were not able to detect overt neurodegeneration or
changes similar to those seen in the ENS or in PD in the brains of Cdnf−/
− mice.
3.6. Amphetamine-induced hyperlocomotion is enhanced in mice lacking
CDNF
We next determined whether dopaminergic neurotransmission was
altered in Cdnf−/− mice. An array of behavioral tests are routinely used
to assess Parkinson-like motor and non-motor phenotypes (Taylor et al.,
2010). We used a novelty-induced locomotor activity test to measure
spontaneous exploration as well as a stress response in an unfamiliar
environment in 7 month-old mice. Baseline activity and habituation in
a novel environment were similar in Cdnf−/− and Cdnf+/+ mice in
both genetic backgrounds, including times spent in corners vs center
(Fig. 7A-B). No differences were seen between genotypes in ex-
ploratory, anxiety (Fig. 7C), or depression-like (Fig. 7D) behavior.
The psychostimulatory drug, D-amphetamine, enters dopaminergic
axon terminals through DAT and interferes with VMAT2-positive DA
storage-vesicles by collapsing pH gradients across the vesicular mem-
brane, eventually causing DA to be displaced from the vesicles into the
cytosol. The events initiated by D-amphetamine cause DAT phosphor-
ylation and eventually reversal of its direction of transport, thereby
transporting DA from the cytosol to the synaptic cleft (Fleckenstein
Table 1
Apoptosis of neurons in the myenteric and submucosal plexuses of the ileum
and colon of juvenile Cdnf+/+ and Cdnf−/− mice.
Plexus Region Genotype N (number mice/total
neurons examined)
Apoptotic neurons
(% total)
Myenteric Ileum Cdnf+/+ 4/22,301 0
Myenteric Ileum Cdnf−/− 5/27,733 0.02 ± 0.02
Myenteric Colon Cdnf+/+ 4/28,819 0
Myenteric Colon Cdnf−/− 6/44,603 0.01 ± 0.01
Submucosal Ileum Cdnf+/+ 4/4989 0.02 ± 0.02
Submucosal Ileum Cdnf−/− 5/4740 0.09 ± 0.03
Submucosal Colon Cdnf+/+ 4/1784 0.07 ± 0.07
Submucosal Colon Cdnf−/− 6/1452 0.12 ± 0.08
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Fig. 4. Neurodegeneration selectively occurs in submucosal neurons of the duodenum, ileum and colon of Cdnf−/− mice. Histochemistry was used with
sections cut in a cryostat-microtome to analyze the proportions of neurons that were degenerating in the ENS of 1.5 month-old mice. Neurons were marked with
ANNA-1 antibodies (magenta), degeneration with Fluoro-Jade C (FJC; green). The proportion of FJC-labeled neurons in the submucosal plexus of the duodenum (A),
ileum (B) and colon (C) of Cdnf−/− mice (magenta bars) is significantly greater than that of their Cdnf+/+ littermates (turquoise bars). In contrast, the proportion of
FJC-labeled neurons in the myenteric plexus of the duodenum (A), ileum (B) and colon (C) of Cdnf−/− mice does not differ significantly from that of their Cdnf+/+
littermates. [A, One way Anova, F (3, 34) =8.398 with Sidak's multiple comparisons to compute the p values shown in the graph; B, One way Anova, F (3, 50)
=21.93 with Sidak's multiple comparisons to compute the p values shown in the graph; C, One way Anova, F (3, 92) =4.357 with Sidak's multiple comparisons to
compute the p values shown in the graph]. (D-L) Images of neurons (D, G, J) with coincident FJC labeling (E, H, K) in the duodenum and ileum of Cdnf+/+ (D, E, F)
and Cdnf−/− (G-L) mice. Merged images are shown in panels F, I, L. Mus = smooth muscle layer; MyP = myenteric plexus; SMP = submucosal plexus. The arrows
point to the locations of FJC-labeled degenerating neurons. The green fluorescence of the muscle layer is due to the non-specific FJC staining of smooth muscle. Scale
bar, 35 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 5. Density of autophagosomes detected with antibodies to LC3 or electron microscopy is greater in enteric neurons of 11 month-old Cdnf−/− than
Cdnf+/+ mice. (A-F) Neurons were marked immunocytochemically with antibodies to ANNA-1 (magenta) and autophagic figures were detected as puncta im-
munostained with antibodies to LC3 (green) in Cdnf+/+ (A-C) and Cdnf−/− mice (D-F). The same fields are illustrated in panel A-C and D-F, illuminated to show the
fluorescence of ANNA-1 (A, D), LC3 (B, E), and the merged images (C, F). Scale bar = 7 μm. (G) The numbers of LC3-immunoreactive autophagic figures per neuron
determined in Cdnf+/+ (green) and Cdnf−/− (magenta) mice are compared. Background level of green fluorescent puncta is also illustrated (white). Autophagy is
significantly greater in Cdnf−/− than in Cdnf+/+ mice; Two-tailed t-test (with Welch's correction) t = 6.062 df = 17.07. (H) Density of autophagosomes was
determined in electron micrographs of submucosal and myenteric neurons of the ileum of Cdnf+/+ (n= 4) and Cdnf−/− (n= 4) mice. Autophagic figures are more
abundant in the submucosal neurons of Cdnf−/− than of Cdnf+/+ animals; two-tailed t-test (with Welch's correction) t= 3.761 df = 87.16). This difference between
genotypes is not apparent in the myenteric plexus (p = .9289, t = 0.08955 df = 82.89). (I) Density of autophagosomes was determined in electron micrographs of
submucosal and myenteric neurons of the colon of Cdnf+/+ (n = 4) and Cdnf−/− (n = 4) mice. Autophagic figures in Cdnf−/− mice are more abundant than in
Cdnf+/+ animals, both in the submucosal (two-tailed t-test t = 3.326, df = 43.49) and myenteric neurons (two-tailed t-test t = 2.296 df = 84.97). (J-M).
Transmission electron microscopic images of autophagosomes (arrows) in submucosal neurons of Cdnf+/+ ileum (J), Cdnf−/− ileum (K), Cdnf+/+ colon (L), and
Cdnf−/− colon (M). Scale bars = 500 nm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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et al., 2007). The net effect of D-amphetamine is thus to elevate levels
of extracellular DA, which prolongs dopaminergic signaling in the
striatum and gives rise to increased locomotor and stereotypic activities
(Yates et al., 2007). In the amphetamine-induced locomotor activity
test we observed no difference between genotypes during the initial
30 min habituation period in 4 month-old and 9 month-old mice
(Fig. 7E-G). According to a two-way ANOVA analysis, however, there
was significant genotype x time interaction in a mixed background in
young adult mice (F(17,306) = 1.8, p = .026) and, in mature adults, in
both mixed (F(17,323) = 2.0, p = .010) and C57BL/6 backgrounds
(F(17,408) = 3.8, p < .0001). These data show that D-amphetamine
causes hyperactivity in mice lacking CDNF. The Fisher LSD post-hoc
(caption on next page)
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analysis, however, revealed differences relative to genotype after D-
amphetamine injections only in 7–9 month-old mice in mixed (Fig. 7F)
and C57BL/6 (Fig. 7G) backgrounds (p < .05 at marked timepoints).
In conclusion, the hyperlocomotor response to D-amphetamine was
significantly greater in Cdnf−/− than in Cdnf+/+ mice in two genetic
backgrounds and age-groups, suggesting that the function of dopami-
nergic neurons is altered in the CNS of Cdnf−/− mice.
3.7. Age-dependent changes in the function of DA axon terminals in CDNF-
deficient mice
We used fast-scan cyclic voltammetry in acute striatal slices to study
the kinetics of DA release and reuptake and the effects of D-ampheta-
mine on dopaminergic axon terminals of the dorsal striatum. The
amounts of DA released were similar in Cdnf+/+ and Cdnf−/− mice
(Fig. 8A); nevertheless, the DA transients in 6 month-old Cdnf−/− mice
Fig. 6. Characterization of midbrain dopamine system in Cdnf−/− and Cdnf+/+ mice. (A-C) Representative pictures of coronal sections from 2 year-old Cdnf+/
+ (upper panel) and Cdnf−/− (lower panel) mouse brains immunostained with antibodies to TH and DAT at the level of the substantia nigra pars compacta (SNpc)
and striatum. Scale bars: A= 100 μm, B-C= 200 μm. (D) Number of TH-positive neurons was quantified in the SNpc from Cdnf+/+ (n = 4) and Cdnf−/− (n = 7)
12 month-old male mice. (E) No differences were found between genotypes in the proportion of dopaminergic neurons quantified from scanned slides of TH-stained
sections of SNpc of 9–12 month-old male mice (n = 2–3 mice/genotype) and SNpc and VTA from 2 year-old male mice (n = 3–4 mice/genotype) (F). TH-positive
striatal fiber densities did not differ between Cdnf+/+ and Cdnf−/− mice quantified from 1 year-old mice (n = 2–3). No differences were found in striatal TH- and
DAT-immunoreactive fiber densities in 2 year-old Cdnf+/+ and Cdnf−/− mice (n = 3–4) mice. (G) Dopamine (DA), DOPAC, HVA, serotonin (5-HT) and 5-HIAA
concentrations were similar in striata from Cdnf+/+ and Cdnf−/− mice measured by HPLC from 9 to 12 month-old male mice (Cdnf+/+ mice n= 10, Cdnf−/− mice,
n = 11, t-test; for DA and DOPAC, Mann Whitney U test). (H–I) qPCR analysis of transcripts encoding UPR-markers in SN (H) and striatum (I) of 9–12 month-old
Cdnf+/+ (n = 3) and Cdnf−/− (n = 5) male mice. (J) qPCR analysis of transcripts encoding Manf in the SN and striatum of 9–12 months Cdnf+/+ (n = 6) and
Cdnf−/− (n = 6) mice. Mean ± SEM, *p < .05.
Fig. 7. Age-dependent increase in amphetamine-induced activity. Novelty-induced locomotor activity measured in 7 month-old mice on mixed or C57BL/6
backgrounds. (A) Distance travelled; mixed ICR background the effect of genotype F(1,19) = 0.8, p = .38, interaction of genotype and time F(11,209) = 1.4,
p = .19; C57BL/6 background effect of genotype F(1,24) = 1.2, p = .28, interaction of genotype and time F(11,264) = 7.6, p = .12; (B) time spent in the center;
mixed ICR background the effect of genotype F(1,19) = 0.1, p = .74, interaction of genotype and time F(11,209) = 0.7, p = .78; C57BL/6 background effect of
genotype F(1,24) = 0.2, p = .63, interaction of genotype and time F(11,264) = 0.4, p = .96; (C) vertical activity, measured for one hour; mixed background the
effect of genotype F(1,19) < 0.001, p= .99, interaction of genotype and time F(11,209) = 0.8, p= .65; C57BL/6 background effect of genotype F(1,24) = 0.008,
p = .93, interaction of genotype and time F(11,264) = 2.0, p = .03; (D) Forced swim test in water-filled cylinder measuring immobility time in for six minutes in
two-minute intervals; mixed background, effect of genotype F(1,19) = 1.6, p= .22, interaction of genotype and time F(2,38) = 0.8, p= .46; C57BL/6 background,
effect of genotype F(1,24) = 1.5, p = .23, genotype by time interaction F(2,48) = 0.5, p = .63 (2-way RM ANOVA). For A-D, male mice used, n = 10–14).
Amphetamine-induced (3 mg/kg) activity was recorded for 90 min (after 30 min habituation in open field) for 4 month-old male mice in mixed ICR genetic
background (E), n= 10; 2-way RM ANOVA the effect of genotype F(1,18) = 2.0, p= .176; time F(17,306) = 12.7, p < .0001; interaction of genotype and time F
(17,306) = 1.8, p = .026; and for 7–9 month-old on mixed background (F), n = 10–11, 2-way RM ANOVA the effect of genotype F(1,19) = 3.3, p = .086; time F
(17,323) = 0.7, p = .840; interaction of genotype and time F(17,323) = 2.0, p = .010; and C57BL/6 background (G), n = 12–14, 2-way RM ANOVA the effect of
genotype F(1,24) = 2.9, p = .102; time F(17,408) = 59.1, p < .0001; interaction of genotype and time F(17,408) = 3.8, p < .0001.
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were wider, that is, their half width (width at half maximum, T ½) was
longer in Cdnf−/− than in Cdnf+/+ animals. The DA transients in
6 month-old Cdnf−/− mice were also significantly wider than in
9–12 month-old Cdnf−/− mice (Fig. 8A). These findings suggest that
the DA re-uptake by DAT was slower in Cdnf−/− mice at 6 months of
age, but this difference between genotypes disappeared during aging.
Perfusing striatal slices with D-amphetamine, causes DA to redis-
tribute out of synaptic vesicles and DAT eventually to transport in re-
verse and to release presynaptic DA, which creates a large extracellular
DA signal. In a voltammetry recording, these events are seen as a re-
duction in fast electrically-stimulated, exocytotic DA transients and as a
slow, but large increase in background DA levels, caused by DAT-
mediated DA efflux (Fig. 8B). Even though the levels of the D-amphe-
tamine-induced, DAT-mediated slow DA efflux seemed quite variable
between recordings, we found that the peak DA concentrations reached
were higher in Cdnf−/− mice especially in 9–12 month-old animals
(Fig. 8C). Interestingly, after beginning the D-amphetamine perfusion,
the reversal of DAT also occurred at an earlier time point in 9–12
month-old Cdnf−/− mice than in 6 month-old Cdnf−/− mice. This same
tendency towards faster DAT reversal in older animals, however, was
seen also in Cdnf+/+ mice; therefore, there was no difference in time to
DAT reversal between genotypes (Fig. 8C). Reduction of the stimulated
exocytotic DA release happened at a similar time course and to a similar
extent in both genotypes at both ages (data not shown), indicating
unaltered kinetics of D-amphetamine uptake into terminals and its ve-
sicular effects in Cdnf−/− mice. Our voltammetry findings suggest that
the high sensitivity to D-amphetamine-induced locomotor activation in
Cdnf−/− mice can be explained by a more pronounced D-amphetamine-
induced DAT reversal in the dorsal striatum of these animals.
To test this hypothesis, we administered GBR 12909 to 1 year-old
Cdnf−/− mice. GBR 12909 is a more selective DAT inhibitor than is D-
amphetamine but GBR 12909 is unable to reverse the direction of DAT-
mediated transmembrane transport. When given GBR 12909, the mice
became activated, as shown by increased locomotor activity in an open
field; however, in contrast to D-amphetamine-induced hyperlocomo-
tion, there was no difference between genotypes (Fig. 8D). This finding
supports the hypothesis that in Cdnf−/− mice the hypersensitivity to D-
amphetamine-induced reversal of DAT explains the phenotype of the
hyperlocomotion seen after D-amphetamine administration.
4. Discussion
In contrast to the poor survival, severe growth defect, and diabetes
ofManf−/− mice (Lindahl et al., 2014), Cdnf−/− mice are viable, fertile
and, in their normal environment, display no gross defects. An age-
dependent loss of enteric neurons, however, occurs in the submucosal
plexus of Cdnf−/− mice, resulting in slower GI motility (Chalazonitis
et al., 2013). In contrast glia density associated with the myenteric and
submucosal plexuses is not affected in Cdnf−/− mice indicating that the
submucosal neurons are impacted selectively. Autophagy, moreover, is
enhanced in neurons of both plexuses of mature adult Cdnf−/− animals.
D-amphetamine-induced hyperactivity was also greater in Cdnf−/−
Fig. 8. Age-dependent changes in the function of DA neurons in Cdnf−/− mice. (A) Striatal slices were stimulated electrically every two minutes to evoke DA
release (see the representative DA trace). The levels of the DA released (Peak max) were similar in Cdnf+/+ and Cdnf−/− mice (F (3, 50) = 0.2092, P= .8896, 2 way
RM ANOVA). The half-widths of the events (T½) were longer in 6 month-old Cdnf−/− mice suggesting that they had slower reuptake of DA than the Cdnf+/+ mice at
this age, but no differences between the genotypes could be found in the 12 month-old mice anymore (genotype: F(3, 50) = 18.04, p < .0001, 2 way RM ANOVA,
## between adult Cdnf+/+ and Cdnf−/−, p= .007, *** between 6 month-old and 12 month-old Cdnf−/−, p < .0001, Tukey's). (B) Representative traces from the
recordings with amphetamine perfused over the striatal slices of Cdnf+/+ and Cdnf−/− mice. Electrically stimulated dopamine transients were evoked at 2 min
intervals. Amphetamine was added to perfusion at @. The reversal of the direction of DAT transport can be seen as a start of a large slow shift in the baseline
representing the DA efflux. (C) The amphetamine-induced DAT-mediated DA efflux was higher in Cdnf−/− mice than in Cdnf+/+ animals, a difference that was more
pronounced in the 12 month-old animals (F(1,21) = 4.673, p= .0423, 2 way ANOVA). DAT reversal occurred at an earlier time point in 12 month-old Cdnf−/− mice
than in 6 month-old Cdnf−/− mice (age: F(1,21) = 10.42, p= .004, two-way ANOVA, * p= .0468, Tukey's). (D) Locomotor activity in an open field arena after GBR
12909 injection (1 year-old mice) was similar in both genotypes (F(1,19) =0.04056, p = .8425, 2 way RM ANOVA).
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than in Cdnf+/+ mice, probably because of altered DAT function in the
midbrain of Cdnf−/− animals.
CDNF is expressed in stomach, small and large intestines as early as
P7 (as well as in the neural crest-derived precursors of enteric neurons
at E16), a time when neurogenesis is highly active in the developing
murine bowel (Chalazonitis et al., 2008; Chalazonitis et al., 2013; Pham
et al., 1991). The expression of CDNF is restricted to neurons in the ENS
of mice (Chalazonitis et al., 2013). The early timing of CDNF expression
is consistent with the idea that CDNF plays a role in ENS development,
which is supported by the observation that 1.5 month- and 3 month-old
Cdnf−/− mice have fewer submucosal neurons than their Cdnf+/+ lit-
termates. The effect of CDNF deletion, which also included enhanced
and selective degeneration of submucosal neurons, persisted in
9–12 month-old mice. In contrast to the submucosal plexus, the density
of myenteric neurons was not significantly changed by the deletion of
CDNF in either the ileum or colon. It is not clear why the submucosal
plexus should be so dependent on CDNF. Submucosal neurons arise
later than myenteric neurons during ontogeny (Chalazonitis et al.,
2008; McKeown et al., 2001; Pham et al., 1991) and their development
depends on a secondary migration of precursors from the myenteric
plexus (Jiang et al., 2003; Payette et al., 1984; Ratcliffe et al., 2008),
which could be influenced by CDNF. The chemically-defined pheno-
types of submucosal neurons are also different from those of the
myenteric plexus (Mongardi Fantaguzzi et al., 2009) and dopaminergic
neurons are more abundant in the submucosal than in the myenteric
plexus (Li et al., 2004, 2011).
The deletion of CDNF did not increase the number of apoptotic
neurons in either enteric plexus. As has been noted previously
(Chalazonitis et al., 2012; Gianino et al., 2003), we found that apoptotic
enteric neurons were vanishingly rare in the ENS of both Cdnf+/+ and
Cdnf−/− 1.5 month-old mice. The deficit in submucosal neurons of
Cdnf−/− mice thus seems not to result from apoptotic cell death. In-
stead, staining with FJC suggests that neurodegeneration contributes to
the selective hypoplasia of submucosal neurons that characterizes
Cdnf−/− mice. Consistent with this observation, the mechanism of
decreased dopaminergic neurons in the substantia nigra of MPTP-
treated mice, has previously been shown to be the consequence of de-
generation rather than apoptosis (Jackson-Lewis et al., 1995; Hung
et al., 2014). Similarly, sustained activation of mitochondrial stress
resulting in UPRMT has been shown to induce a non-apoptotic degen-
eration of dopamine neurons in C. elegansmodels of PD (Martinez et al.,
2017). Autophagy, furthermore, was greater throughout the ENS of
9–12 month-old Cdnf−/− mice than in Cdnf+/+ animals. Because au-
tophagy may be a cellular response to stress, these data support the idea
that alleviation of stress is a function of CDNF (Voutilainen et al., 2017;
Zhang et al., 2018). Taken together, these data suggest that in addition
to promoting development of neurons in fetal mice (Chalazonitis et al.,
2010; Chalazonitis et al., 2013), CDNF exerts a sustained protective
effect on submucosal neurons in post-natal animals.
Degeneration of vulnerable enteric neurons, and slowing of GI
motility (Chalazonitis et al., 2013) with no major impairment of mid-
brain neurons function exhibited by the Cdnf−/− mice, could represent
a phenotype reminiscent of early, pre-motor symptomatic PD. Inter-
estingly alpha-synuclein has been shown to accumulate in the colonic
submucosa in early untreated PD (Shannon et al., 2012; Beach et al.,
2016; Fenyi et al., 2019); moreover, PD is not associated with loss of
myenteric neurons and PD-related GI dysmotility is considered to be
more likely due to damage in the submucosal plexus (Annerino et al.,
2012).
Even though the ENS was highly affected by the deletion of CDNF,
the number of dopaminergic neurons in the SN, the densities of their
striatal projections, and the striatal DA concentrations were similar in
Cdnf−/− and Cdnf+/+ mice. Although both CDNF and MANF have been
implicated in ER stress, we found no signs of abnormal activation of the
UPR in the SN or striata of Cdnf−/− mice. Various behavioral tests were
used to assess motor and non-motor phenotypes that resemble those
seen in PD. We found no difference between genotypes in baseline ac-
tivity and habituation in a novel environment nor in exploratory, an-
xiety or depression-like behavior. An increase in D-amphetamine-in-
duced hyperlocomotion, however, was detected in Cdnf−/− mice in two
different genetic backgrounds, indicating that loss of CDNF leads to
changes in the function of brain dopaminergic neurons.
Because D-amphetamine stimulates DA release through DAT, we
used cyclic voltammetry to examine DA release and reuptake in striatal
brain slices. Electrical stimulation released similar amounts of DA from
both Cdnf−/− and Cdnf+/+ dorsal striatal dopaminergic terminals;
however, in the 6 month-old animals, the DA reuptake was significantly
slower in Cdnf−/− mice. This difference disappeared in older mice.
Although the mechanisms behind the observed difference are unclear,
age-dependent changes in the kinetics of DAT-mediated DA reuptake
have been described in earlier studies. One study showed faster DA
reuptake kinetics together with higher amounts of DAT in the striatum
of 5–6 week-old rats than in 12–13 week-old rats (Volz et al., 2009).
Another study described complex alterations in release and reuptake
kinetics in young, adult or aged rats with adults having the highest DA
release and reuptake (Stamford, 1989). In part, these differences can be
explained by age-dependent changes in phosphorylation and glycosy-
lation of DAT (Cruz-Muros et al., 2009).
Importantly, the D-amphetamine-induced DAT-mediated DA efflux
was greater in Cdnf−/− mice than in Cdnf+/+ mice, which could ex-
plain the stronger locomotor activation of Cdnf−/− mice after D-am-
phetamine administration. Another stimulatory drug, GBR 12909, a
DAT-inhibitor that does not reverse DAT-mediated transport was used
to test this hypothesis. GBR 12909 stimulated the locomotor activity of
both genotypes to a similar extent, suggesting that the difference in D-
amphetamine's effects on Cdnf−/− mice depends on altered regulation
of the reversal of DAT-mediated transport. Our voltammetry data also
revealed that, independently of genotype, in older mice, the D-am-
phetamine-induced DAT reversal occurred faster than in younger ani-
mals and there was also a trend towards higher extracellular DA levels
due to DAT-mediated DA release. These observations suggest that
during aging, DAT becomes more vulnerable to the D-amphetamine-
induced reversal of the direction of DA transport, possibly because DAT
becomes more susceptible to phosphorylation through PKCβ (Chen
et al., 2009).
The contrast between the much greater phenotypic severities of
CDNF-deficiency in the ENS than in the brain is striking. The hypoplasia
of neurons that occurs selectively in submucosal but not myenteric
neurons with no loss of midbrain dopaminergic neurons in Cdnf−/−
mice suggests that CDNF could be required for the development/sur-
vival of neurons in the ENS but not in the brain. Compensation by other
factors for the absence of CDNF in the brain may occur, as has been
shown for numerous rodent knockout models, in which compensatory
processes have masked expected neurodegenerative phenotypes
(Dawson et al., 2010). MANF, the orthologue of CDNF, is expressed in
the developing and adult nigrostriatal system in rodent brain and at low
levels in neurons of the submucosal and myenteric ganglia (Lindholm
et al., 2008; Wang et al., 2014, Supplemental Fig. 2A). Since MANF
expression levels in the nigrostriatal pathway are high, we cannot rule
out the possibility that MANF compensates for CDNF depletion. Ana-
lysis of adult brain in CDNF-MANF double knockout mice would reveal
whether these factors can compensate for one another. The greater
sensitivity of enteric than CNS neurons to the absence of CDNF in mice
might reflect the severe downregulation of GDNF expression in adult
gut because enteric neurons are highly GDNF-dependent (Golden et al.,
1999). Alternatively, submucosal enteric neurons might be more de-
pendent on the protective effect of CDNF because they are subject to
constitutive mechanical stress from intestinal smooth muscle contrac-
tions. Stress in the form of inflammation caused by invasion of bacteria
into the intestinal lumen also causes degeneration of enteric neurons
which increases as a function of age (Becker et al., 2018). The brain is
less exposed to inflammation than the gut because of the protecting
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blood-brain barrier and the absence of a large constitutive microbiome.
There is also reason to believe that the submucosal plexus, which is
more sensitive than the myenteric to CDNF-deficiency, is also more
subject to stress. The myenteric, but not the submucosal plexus is
protected by a blood-tissue barrier that is analogous to the blood-brain
barrier (Gershon and Bursztajn, 1978).
This is the first study to analyze the function of endogenous CDNF in
mammals. The ENS and brain dopaminergic phenotypes in Cdnf−/−
mice that we have discovered reveal novel in vivo actions of CDNF. We
also report, for the first time, that CDNF is critical for the development/
maintenance of enteric submucosal neurons; moreover, in the aging
brain, CDNF plays a role in dopaminergic function through the reg-
ulation of DAT function in striatal dopaminergic axon terminals.
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